Wave Life Sciences WVE
NASDAQ WVE
$4.85 +0.15 (+3.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Wave Life Sciences (WVE) Other Non-Current Assets (2014 - 2026)

Wave Life Sciences' (WVE) quarterly Other Non-Current Assets came in at $3.8 million in Q2 2026, up 0.82% YoY from $3.8 million in Q2 2025, and little changed on a QoQ basis from $3.8 million in Q1 2026.

Analysis

Wave Life Sciences (WVE) Other Non-Current Assets (2014 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 12 years of Other Non-Current Assets data on file, last reported at $3.8 million in Q2 2026.

  • Quarterly Other Non-Current Assets rose 0.82% year-over-year to $3.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.8 million (up 0.82% YoY) and the FY2025 annual result came in at $3.8 million, changed 0.16% from the prior year.
  • Other Non-Current Assets held at $3.8 million in Q2 2026, from $3.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.7 million in Q1 2023 to a low of $3.7 million in Q1 2022.
  • A 5-year average of $3.8 million and a median of $3.7 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets advanced 27.64% — and 2024, when it dropped 20.28%.
  • Tracing WVE's Other Non-Current Assets over 5 years: stood at $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then grew by 2.7% to $3.8 million in 2024, then increased by 0.16% to $3.8 million in 2025, then gained by 0.24% to $3.8 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.8 million (Q2 2026), $3.8 million (Q1 2026), and $3.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Wave Life Sciences 994.54 Mn 626.53 Mn - 3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.82 Mn
Mar 31, 2026 3.82 Mn
Dec 31, 2025 3.81 Mn
Sep 30, 2025 3.80 Mn
Jun 30, 2025 3.78 Mn
Mar 31, 2025 3.77 Mn
Dec 31, 2024 3.80 Mn
Sep 30, 2024 3.75 Mn
Jun 30, 2024 3.73 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 3.70 Mn
Sep 30, 2023 3.68 Mn
Jun 30, 2023 3.67 Mn
Mar 31, 2023 4.66 Mn
Dec 31, 2022 3.70 Mn
Sep 30, 2022 3.65 Mn
Jun 30, 2022 3.65 Mn
Mar 31, 2022 3.65 Mn
Dec 31, 2021 3.70 Mn
Sep 30, 2021 3.65 Mn